AKAnne Karow

Anne Karow

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anne Karow has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evidenzbasierte Implementierung von stationsäquivalenter Behandlung in Deutschland

    by Martin Lambert, Anne Karow, Jürgen Gallinat, Arno Deister, Deutscher Bundestag, S Johnson, J Needle, J P Bindman, G Thornicroft, M Smyth, et al.

    2016 hat die Bundesregierung das „Gesetz zur Weiterentwicklung der Versorgung und der Vergütung für psychiatrische und psychosomatische Leistungen“ (PsychVVG) beschlossen [1]. Zur Förderung der sektorenübergreifenden Versorgung wurde der § 39 Absatz 1 des Fünften Buches Sozialgesetzbuch (SGB V) geändert: „Die Krankenhausbehandlung wird vollstationär, stationsäquivalent, teilstationär, vor- und nachstationär sowie ambulant erbracht.“


  • Früherkennung und integrierte Versorgung von Jugendlichen und jungen Erwachsenen mit schweren psychotischen Erkrankungen

    by Martin Lambert, Daniel Schöttle, Mary Sengutta, Daniel Lüdecke, Antonia-Luise Nawara, Britta Galling, Ute Handwerk, Wiebke Rothländer, Anne-Lena Falk, Liz Rietschel, et al.

    Prospektive 1-Jahres-Follow-up-Untersuchung in der kombinierte multidimensionale Früherkennung und alters- und fachübergreifende integrierte Versorgung (Interventionsbedingung, n = 120) mit einer Standardbehandlung (historische Kontrollgruppe, n = 105) bei Jugendlichen und jungen Erwachsenen in der frühen Phase einer psychotischen Störung verglichen wird. Daten bei Aufnahme in die Studie weisen auf eine hohe Komplexität und Schwere der Erkrankung hin. Primäres Zielkriterium ist die Rate einer 6-monatigen kombiniert symptomatischen und funktionalen Remission zum Studienendpunkt. This is a prospective 1-year follow-up study comparing a combined intervention consisting of multidimensional early detection strategies with age- and interdisciplinary integrated care (intervention group, n = 120) with standard care (historical control group, n = 105) in adolescents and young adults within the early phase of psychosis. Data at study entry indicate a high complexity and severity of illness. Primary outcome is the 6-month rate of combined symptomatic and functional remission at study endpoint.


  • Verbesserung von Aufklärung, Wissen und Stigmatisierung psychischer Erkrankungen in der Hamburger Bevölkerung

    by Martin Lambert, Martin Härter, Detlef Arnold, Jörg Dirmaier, Lisa Tlach, Sarah Liebherz, Sylvia Sänger, Anne Karow, Andreas Brandes, Gyöngyver Sielaff, et al.

    Studien zeigen, dass ein unzureichendes Wissen über psychische Erkrankungen und Stigmatisierungen negative Konsequenzen für die mentale Gesundheit haben. Jedoch sind Studien zu deren Verbesserung in Methodik und Ergebnis oftmals heterogen. Die Hamburger psychenet-Kampagne entstand in Zusammenarbeit mit Betroffenen und Angehörigen und umfasste eine multimodale Intervention zur Förderung von Wissen und Kontakt zu Betroffenen. Ziele waren die Verbesserung von Aufklärung, Wissen und Stigmatisierung sowie die Verstetigung innerhalb des Hamburger Versorgungssystems. Evidence shows that poor mental health literacy and stigmatization have negative consequences on mental health. However, studies on interventions to improve both are often heterogenic in methodology and results. The psychenet-campaign in Hamburg was developed and implemented in collaboration with patients and relatives and comprised multidimensional interventions focusing on education and contact to patients. The main goals were the improvement of mental health literacy and destigmatization and the long-term implementation within Hamburg’s mental health care system.


  • The other side of “madness”: frequencies of positive and ambivalent attitudes towards prominent positive symptoms in psychosis

    by Steffen Moritz, Liz Rietschel, Ruth Veckenstedt, Francesca Bohn, Brooke C. Schneider, Tania M. Lincoln, Anne Karow

    Background: Phenomenological descriptions of psychosis traditionally emphasize the subjective burden that psychosis inflicts on patients. However, a growing body of work suggests that in a subgroup of patients, psychotic symptoms are appraised as positive. The present study set out to explore the frequency of positive, negative and ambivalent attitudes towards positive symptoms. We were also interested in characterizing the phenomenological structure of positive symptoms. Method: Participants were recruited over the Internet via specialized psychosis forums. Among other questionnaires, participants completed the Community Assessment of Psychic Experiences (CAPE) scale. In addition, we administered a novel scale called Subjective Perception of Positive Symptoms (SUPPOSY) that assesses core positive symptoms along various dimensions (e.g. emotional appraisal, impact on daily life). Results: For all symptom clusters, the majority of participants expressed ambivalence. Psychotic symptoms were associated with both self-reported positive and negative emotions. Experiencing regret should positive symptoms disappear was associated with prior medication noncompliance. Discussion: The present study indicates that symptoms are neither regarded as an “emotional hell” nor as a “preferred reality”. Thus, for a symptom to become a target of treatment, various aspects of the symptom have to be carefully weighed.


  • Physical and mental health in severe opioid‐dependent patients within a randomized controlled maintenance treatment trial

    by Jens Reimer, Uwe Verthein, Anne Karow, Ingo Schäfer, Dieter Naber, Christian Haasen

    Aims To evaluate physical and mental health and compare treatment outcomes in opiate‐dependent patients substituted either with heroin or methadone. Design Twelve‐month open‐label randomized controlled trial. Setting Out‐patient substitution clinics in seven German cities. Participants A total of 1015 opiate‐dependent individuals. Measurements Opiate Treatment Index–Health Scale Score (OTI), Body Mass Index (BMI), serology for infectious diseases such as hepatitis B, C and human immunodeficiency virus as well as tuberculosis, Karnofsky Performance Scale (KPS), electrocardiogram (ECG), echocardiogram, Symptom Checklist 90‐R (SCL‐90‐R), Global Assessment of Functioning (GAF), Modular System for Quality of Life and study medication‐related serious adverse events (SAE). Findings Improvements were found in both heroin and methadone substituted patients regarding OTI, BMI, KPS, SCL‐90‐R, and GAF, but they were more pronounced for the heroin group (analysis of variance, all P = 0.000). The frequency of pathological echocardiograms decreased in the heroin group and increased in the methadone group (χ2 test, <0.05). Markers for infectious diseases and frequencies of pathological ECGs did not differ between baseline and 12 months, or between treatment groups. Study medication‐related serious adverse events, all of which were treated successfully, occurred 2.5 times more often in the heroin group. The majority of heroin‐related SAEs (41 of 58) occurred within a few minutes of the injections. Conclusions The integration of severe injection drug users either in methadone or heroin‐assisted maintenance treatment has positive effects on most physical and mental change‐sensitive variables, with heroin showing superior results. Due to medication‐related adverse events, patients should be observed for 15 minutes after a heroin injection.


  • Positivsymptome und Lebensqualität aus der Sicht schizophrener Patienten

    by Anne Karow, Ingo Schäfer, Florian Hirdes, Claudia Osterwald, Dieter Naber

    Anliegen Die Untersuchung von Positivsymptomen und Lebensqualität aus der Sicht schizophrener Patienten. Methode Bei 59 Patienten wurden selbst- und fremdbewertete Positivsymptome (semistrukturiertes Interview), Psychopathologie (PANSS), subjektive Befindlichkeit (SWN) und Lebensqualität (MSLQ) untersucht. Ergebnisse Größenideen und dialogisierende Stimmen waren subjektiv weniger beeinträchtigend als imperative, abwertende Stimmen oder Verfolgungsideen. Patienten mit hoher Beeinträchtigung durch ihre Symptome berichteten eine signifikant schlechtere subjektive Befindlichkeit (SWN: t = 2,27; p < 0,05) und Lebensqualität (MSLQ: t = 2,01; p < 0,05), unterschieden sich jedoch nicht hinsichtlich der Schwere ihrer Symptome von Patienten mit geringer Beeinträchtigung (PANSS: t = − 0,98; p = n. s.). Schlussfolgerung Die subjektive Beeinträchtigung durch Positivsymptome spiegelt die individuelle Bedeutung der Symptome wider und ist mit schlechterer Lebensqualität assoziiert. Objective The aim of the study was the investigation of positive symptoms and quality of life from the subjective perspective of patients with schizophrenia. Methods We assessed self- and expert-rated positive symptoms (semi-structured interview), standardized psychopathology (PANSS), subjective well-being (SWN) and QOL (MSLQ) in n = 59 patients. Results Patients reported that ideas of grandiosity and hallucinations of dialogue voices were less distressing compared with command voices, malevolent voices and delusional ideas of persecution. Patients with high levels of distress reported significant lower subjective well-being (SWN: t = 2.27; p < 0.05) and QOL (MSLQ: t = 2.01; p < 0.05), but showed no differences in symptom severity (PANSS: t = − 0,98; p = n. s.) compared with patients with low subjective distress. Conclusions Distress caused by positive symptoms reflected the individual meaning of the symptoms and was associated with lower quality of life.


  • Association of Personality Disorders, Family Conflicts and Treatment with Quality of Life in Opiate Addiction

    by A. Karow, U. Verthein, M. Krausz, I. Schäfer

    Aim: The purpose of this study was to investigate the association of the current status and longitudinal changes in different clinical and social variables with quality of life (QOL) in opiate addiction. Our hypotheses were that drug use, comorbid personality disorders and social problems are associated with worse QOL. Methods: 107 participants with long-term opiate addiction were included and interviewed at entry with the Europ-ASI and the PDQ-R. QOL (SF-36) and changes in different domains of the Europ-ASI were assessed after 2 years. Results: Personality disorders, interpersonal conflicts with the family or partner and ongoing need for somatic and psychiatric treatment were significantly associated with worse subjective QOL, whereas changes in drug and alcohol use, the economic situation, legal problems and social problems with persons outside of the family showed no relevant association with QOL. Conclusion: Our results provide support for an emphasis in treatment on helping clients to reduce intra- and interpersonal conflicts according to comorbid conditions and among family members and partnerships. In addition, the present data provide further support for the advantages of extended interventions in long-term opiate addiction.


  • The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life

    by A. Karow, F.-G. Pajonk, J. Reimer, F. Hirdes, C. Osterwald, D. Naber, S. Moritz

    A major subgroup of patients with acute schizophrenia lacks awareness of having a mental disorder. The aim of this study was to investigate the association of self- and expert-rated insight into illness with subjective quality of life (QOL). It was hypothesised that patients with greater self- and expert-rated insight into illness report lower QOL compared to patients with poor insight.


  • Association of Subjective Well-Being, Symptoms, and Side Effects With Compliance After 12 Months of Treatment in Schizophrenia

    by Anne Karow, Joerg Czekalla, Ralf W. Dittmann, Alexander Schacht, Thomas Wagner, Martin Lambert, Benno G. Schimmelmann, Dieter Naber

    Subjective well-being is considered important for compliance with antipsychotic treatment. The objective of this post hoc analysis of data from German patients in the Schizophrenia Outpatient Health Outcomes study was to investigate subjective well-being and compliance, with consideration of clinical symptoms and side effects, in outpatients diagnosed with schizophrenia. In a multicenter observational study of 2960 patients with DSM-IV-defined schizophrenia recruited between January and December 2001, subjective well-being was measured during 12 months with the Subjective Well-Being Under Neuroleptic Treatment Scale, short version (SWN-K). Compliance was self- and physician-rated. The association of compliance with clinical parameters was assessed by logistic regression. Factor analysis resulted in 3 factors: SWN-K (r2 = 0.867), clinical symptoms (r2 = 0.744), and side effects (r2 = 0.420). The odds for being compliant were 1.363 times higher if the SWN-K score increased by 20 points. Changes in positive symptoms (OR = 0.773) and changes in extrapyramidal symptoms (OR = 0.830) were found to be associated with compliance. Compliance with antipsychotic medication was strongly associated with subjective well-being; further factors were clinical symptoms and side effects.